GAIN

Business Context and Reporting Period

Company: Gladstone Investment Corporation (GAIN)
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2016
Business Overview: Gladstone is an externally advised, closed-end, non-diversified management investment company operating as a Business Development Company (BDC) and a Regulated Investment Company (RIC). It invests in debt and equity securities of established private U.S. businesses. As of September 30, 2016, the portfolio consisted of 36 companies with a total fair value of $486.0 million.

Key Financial Metrics

Material Changes vs. Prior Period

• Net Income Volatility: The six-month period ended September 30, 2016, showed a significant net increase in net assets of $24.4 million, driven by an $18.8 million realized gain from the sale of Acme Cryogenics, Inc. In contrast, the three-month period ended September 30, 2016, resulted in a net decrease of $0.1 million due to $5.0 million in unrealized depreciation.
• Investment Income: Total investment income decreased 14.5% in the three-month period compared to the prior year, primarily due to a 99.2% drop in other income (dividends/success fees). For the six-month period, total investment income was relatively flat (down 1.2%).
• Expense Reduction: Total expenses, net of credits, decreased 14.1% in the three-month period and 6.9% in the six-month period compared to the prior year, largely due to lower incentive fees and increased voluntary fee credits from the Adviser.
• Portfolio Composition: The portfolio fair value decreased slightly from $487.7 million at March 31, 2016, to $486.0 million at September 30, 2016. The portfolio remains 72.5% debt and 27.5% equity at fair value.

Guidance, Outlook, and Risks

• Capital Markets Activity: In September 2016, the Company completed a public offering of 2.3 million shares of 6.25% Series D Term Preferred Stock, raising $57.5 million in gross proceeds. Proceeds were used to voluntarily redeem all 1.6 million shares of the 7.125% Series A Term Preferred Stock ($40.0 million).
• Subsequent Events: In October 2016, the Company restructured its investment in D.P.M.S., Inc., resulting in a realized loss of $10.2 million. This transaction involved exchanging existing debt and equity for a new secured first lien term loan.
• Liquidity: The Company maintains a $185.0 million revolving credit facility. As of September 30, 2016, $63.5 million was outstanding, with $121.5 million in availability (subject to borrowing base constraints). The Company is in compliance with all covenants, including a 200% asset coverage ratio.
• Risks: Key risks include the valuation of private investments (Level 3 inputs), interest rate fluctuations affecting net investment income, and the ability to raise equity capital when the stock trades below NAV. The common stock traded at an 11.6% discount to NAV as of November 1, 2016.

Investor Verification Checklist

• Realized Gain Sustainability: Verify the impact of the $18.8 million one-time gain from the Acme Cryogenics exit on the six-month results versus the recurring income generation capability.
• Unrealized Depreciation Drivers: Review the specific portfolio companies contributing to the $5.0 million unrealized depreciation in Q3 2016 (e.g., D.P.M.S., Inc., SBS Industries, LLC) to assess credit quality trends.
• Subsequent Restructuring Impact: Assess the financial impact of the October 2016 D.P.M.S. Inc. restructuring and the associated $10.2 million realized loss on future earnings.
• Preferred Stock Obligations: Confirm the dividend obligations and mandatory redemption dates for the outstanding Series B, C, and D Term Preferred Stock ($139.2 million aggregate liquidation preference).
• Fee Credits: Analyze the sustainability of the voluntary fee credits from the Adviser, which significantly reduced the net expense ratio.